newsfilter
← Latest News
GlobeNewswire·

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

Single ascending dose data readout for VTP-1000 expected before the end of 2025Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in the second half of 2026Proposed combination with